A Comparative Study with Two Administration Schedules of Leucovorin and 5-Fluorouracil in Advanced Colorectal Cancer

REFERENCES

• Pinedo HM, Peters GFJ. Fluorouracil: biochemistry and pharmacology. J Clin Oncol 1988; 6: 1653–1664.
   PubMed Web of Science ®Google Scholar
• Grem JL, Hoth DF, Hamilton JM, King SA, Leyland-Jones B. Overview of current status and future directions of clinical trials with 5-fluorouracil in combination with folinic acid. Cancer Treat Rep 1987; 71: 1249-1264.
   Google Scholar
• Zheng-Gang Z, Harstrick A, Rustum YM. Modulation of fluoropyrimidines: role dose and schedule of leucovorin administration. Semin Oncol 1992; 19: 10–15.
   Web of Science ®Google Scholar
• Petrelli N, Herrera L, Rustum Y, et al. A prospective randomized trial of 5-fluorouracil versus 5-fluorouracil and high dose leucovorin versus 5-fluorouracil and methotrexate in previously untreated patients with advanced colorectal car-cinoma. J Clin Oncol 1987; 5: 1559-1565.
   Google Scholar
• Petrelli N, Douglas HO, Herrera L, et al. (Gastrointestinal Tumor Study Group). The modulation of fluorouracil with leucovorin in metastatic colorectal carcino-ma: a prospective randomized phase III trial. J Clin Oncol 1989; 7: 1419-1426.
   Google Scholar
• O'Connell MJ. A phase III trial of 5-fluorouracil and leucovorin in the treatment of advanced colorectal cancer. Cancer 1989; 63: 1026-1030.
   Google Scholar
• Ehrlichman C, Fines S, Wong A, et al. Randomized trial of fluorouracil and folinic acid in patients with metastatic col-orectal carcinoma. J Clin Oncol 1988; 6: 469–475.
   PubMed Web of Science ®Google Scholar
• Valone FH, Friedman MA, Wittinger PS, et al. Treatment of patients with advanced colorectal carcinoma with fluorouracil alone, high dose leucovorin plus fluo-rouracil, or sequential methotrexate, fluorouracil and leucov-orin: a randomized trial of the Northen California Oncol Group. J Clin Oncol 1989; 7: 1427–1436.
   PubMed Web of Science ®Google Scholar
• Doroshow JH, Multhauf P, Leong L, et al. Prospective randomized comparison of fluorouracil versus fluorouracil and high dose continuous infusion leucovorin calcium for the treatment of advanced measurable colorectal cancer in patients previously unexposed to chemotherapy. J Clin Oncol 1990; 8: 491–501.
   PubMed Web of Science ®Google Scholar
• Nobile MT, Canobbio L, Sobreno A, et al. A random-ized trial of 5 -fluorouracil and high dose leucovorin in untreated advanced colorectal cancer patients. Adv Exp Med Biol 1988; 244: 213–218.
   PubMedGoogle Scholar
• Labianca R, Pancera G, Aitini E, et al. Folinic acid + 5-Fluorouracil versus equidose 5FU in advanced colorectal can-cer: phase III study of GISCAD. Ann Oncol 1991; 2: 673–679.
   PubMed Web of Science ®Google Scholar
• Piedbois P, Buyse M, Rustum Y, et al. Meta-analysis of 5-FU and Leucovorin in patients with advanced colorectal cancer. Symposium on new trends in biochemical modulation of 5-Fluorouracil with leucovorin. XVII Congress ESMO 7/11/1992, Lyon, France.
   Google Scholar
• Madajewics S, Petreffi N, Rastum YM, et al. Phase I-II trial and high dose calcium leukovorin and 5-fluorouracil in advanced colorectal cancer. Cancer Res 1984; 44: 4667-4669.
   Google Scholar
• Budd GT, Fleming RM, Bukowsky RM, et al. 5-Fluorouracil and folinic acid in the treatment of metastatic colorectal cancer: a randomized comparison. A Southwest Oncology Group Study. J Clin Oncol 1987; 5: 272–277.
   PubMed Web of Science ®Google Scholar
• Cunningham J, Bukowsky RM, Budd GT, Weicke JK, Purvis J. 5-Fluorouracil and folinic acid. A phase I-II trial in gastrointestinal malignancy. Invest New Drugs 1984; 2: 391–395.
   PubMed Web of Science ®Google Scholar
• Laufmann LR, Kreczowski KA, Roach R, Segal M. Leucovorin plus 5-fluorouracil: an effective treatment for metastatic colon cancer. J Clin Oncol 1987; 5: 1394-1400.
   Google Scholar
• Machover D, Scwarzenberg L, Goldsmith E, et al. Treatment of advanced colorectal and gastric adenocarcinoma with 5FU combined with high dose folinic acid: a pilot study. Cancer Treat Rep 1982; 66: 1803-1807.
   Google Scholar
• Machover D, Goldsmidt E, Chollet P, et al. Treatment of advanced colorectal and gastric adenocarcinoma with 5-Fluorouracil and high dose folinic acid. J Clin Oncol 1986; 4: 685–696.
   PubMed Web of Science ®Google Scholar
• Gerstner J, O'Connell MJ, Wieand HS, et al. Randomized comparison of two schedules of fluorouracil and leucovorin in the treatment of advanced colorectal cancer. J Clin Oncol 1994; 12: 14–20.
   PubMed Web of Science ®Google Scholar
• Miller A, Hoogstraten B, Staquet M, Winkler A. Reporting results of cancer treatment. Cancer 1981; 47: 207–217.
   PubMed Web of Science ®Google Scholar
• Kaplan EL, Meier P. Non parametric estimation for incomplete observations. J Am Stat Assoc 1958; 53: 457–481.
   Web of Science ®Google Scholar
• Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 1966; 50: 163–170.
   PubMedGoogle Scholar
• Tsavaris N, Bacoyannis C, Milonakis N, Sarafidou M, Zamanis N, Magoulas D, Kosmidis P. Folinic acid plus high dose 5-fluorouracil with allopurinol protection in the treat-ment of advanced colorectal cancer. Eur J Cancer 1990; 26: 1054-1056.
   Google Scholar
• Tsavaris N, Tzannou I, Karvounis N, Kosmidis P. The continuous 24 hours infusion of folinic acid did not increase the response rate of fluorouracil but only toxicity. Oncology 1992, 49: 154–156.
   PubMed Web of Science ®Google Scholar
• Fountzilas G, Zisiadis A, Kosmidis P, et al. High dose leucovorin, fluorouracil and oral dipyridamol in the treatment of advanced colorectal cancer. Anticancer Res 1991; 3: 183–188.
   Google Scholar
• Lokich JJ. Optimal schedule for 5-fluorouracil chemotherapy. Am J Clin Oncol 1985; 8: 445–448.
   PubMed Web of Science ®Google Scholar
• Tsavaris N, Karagiaouris P, Vonorta K, et al. Concomitant administration of 4-hydroxypyrazolopyrimidine (allopurinol) and high dose continuous infusion 5-fluo-rouracil. Oncology 1990; 47: 70–74.
   PubMed Web of Science ®Google Scholar